Lagoda Investment Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.61M Buy
37,365
+955
+3% +$104K 3.08% 13
2026
Q1
$3.36M Buy
36,410
+4,905
+16% +$492K 2.07% 15
2025
Q4
$3.22M Buy
+31,505
New +$2.82M 1.86% 16

Other funds holding GH

Lagoda Investment Management's GH Position: Q2 2026 in Review

Lagoda Investment Management increased its Guardant Health (GH) stake by 2.6% in Q2 2026, buying an estimated $104K and bringing the position to 37,365 shares worth $5.61M. The position accounts for 3.08% of the portfolio, ranked #13.

Lagoda Investment Management first reported a position in GH in Q4 2025 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Lagoda Investment Management held 37,365 shares of Guardant Health worth $5.61M as of Q2 2026.
  • Lagoda Investment Management bought 955 Guardant Health shares in Q2 2026, an estimated $104K.
  • Guardant Health made up 3.08% of Lagoda Investment Management's portfolio in Q2 2026, its #13 holding.
  • Lagoda Investment Management first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Lagoda Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.